Cancer

(SLB-017) A real-world database study of myelodysplastic syndrome and acute myeloid leukemia in prostate cancer patients

(A-050) Association of Glucagon-Like Peptide 1 Receptor Agonists with Cancer Risk in Older Adults with Type 2 Diabetes: A Target Trial Emulation Study

(SLB-023) Cardiovascular Adverse Events of Endocrine Therapies in Women with Breast Cancer: A Disproportionality Analysis Using FAERS

(SLB-021) Characterization and Incidence of Breast Cancer Amongst Females in the United Kingdom: An Analysis of Real-World Data from THIN® UK Database and Comparability with Findings from the CPRD GOLD Database

(SLB-022) Concordance between blinded independent central review committee and physician-assessed responses: Analyses based on a real-world external control arm in relapsed/refractory multiple myeloma using IMWG data

(SLB-018) Immune-related Adverse Events (irAEs) associated with Immune Checkpoint Inhibitor (ICI) Therapy in Bladder Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials

(SLB-024) Improved Survival Outcomes in Cancer Patients with Autoimmune Skin Diseases Receiving Immune Checkpoint Inhibitors: A Nationwide Cohort Study

(SLB-019) Predicting the Risk of Non-Small Cell Lung Cancer through Polygenic Approach: A US Based Study

(A-049) Prevalence Predictive Modelling of HER2 status in Non-Small Cell Lung Cancer in large multicenter data using machine learning approach and application to SEER: A pilot test

(SLB-020) Risk of Secondary Primary Malignancies among Patients with Selected Hematologic Cancers: US population-based analysis of SEER